Why did Haleon's shares fall despite reporting a profit beat?

Haleon's shares fell because, although its first-half adjusted operating profit of £1.36 billion exceeded expectations of £1.32 billion, investors were concerned about sluggish European demand and a steeper-than-expected 6.5% decline in respiratory sales — worsening from a 3.4% drop in the first quarter — raising doubts about the company's ability to achieve its medium-term organic revenue growth target of 4% to 6%.

What factors are undermining Haleon's sales growth, particularly in Europe and respiratory categories?

Sluggish European demand — resulting in nearly flat organic revenue growth there — and a 6.5% decline in respiratory sales (driven by a weak flu season across North America, Europe, and China) are key factors undermining Haleon's sales growth; additionally, higher freight expenses linked to the Iran war and declining consumer sentiment in markets like Dubai have further weighed on performance.

Haleon Shares Slip Despite Profit Beat Amid Sales Growth Concerns

Jul 29, 2026

Haleon reported a first-half profit beat but saw shares slip due to weak European demand and falling respiratory sales. While operating profits exceeded expectations, analysts remain cautious about meeting medium-term growth targets amid rising freight costs.

reuters

2026-07-29

Haleon Shares Slip Despite Profit Beat Amid Sales Growth Concerns

Haleon Shares Slip Despite Profit Beat Amid Sales Growth Concerns

FAQ